HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulf de Faire Selected Research

Cytokine Receptor gp130

8/2021IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation.
1/2021Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.
1/2020Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study.
6/2015Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulf de Faire Research Topics

Disease

39Myocardial Infarction
01/2022 - 03/2002
37Hypertension (High Blood Pressure)
12/2016 - 01/2001
35Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2002
31Atherosclerosis
01/2022 - 01/2001
23Stroke (Strokes)
01/2022 - 03/2002
21Coronary Disease (Coronary Heart Disease)
01/2022 - 08/2002
20Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2014 - 03/2002
14Inflammation (Inflammations)
01/2020 - 12/2007
12Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 09/2002
8Type 2 Diabetes Mellitus (MODY)
12/2016 - 11/2005
8Insulin Resistance
10/2016 - 07/2004
7Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 12/2005
7Ischemic Stroke
08/2021 - 04/2009
7Carotid Artery Diseases
01/2021 - 11/2003
5Diabetes Mellitus
01/2019 - 09/2002
5Obesity
03/2016 - 11/2004
4Atherosclerotic Plaque (Atheroma)
01/2021 - 01/2010
4Thrombosis (Thrombus)
01/2014 - 05/2009
4Rheumatoid Arthritis
06/2012 - 06/2004
3Overweight
03/2016 - 06/2003
3Alzheimer Disease (Alzheimer's Disease)
01/2010 - 04/2003
2Hypercholesterolemia
01/2022 - 01/2005
2Hyperplasia
01/2020 - 01/2016
2Neoplasms (Cancer)
01/2019 - 01/2018
2Heart Failure
01/2019 - 08/2007
2Unstable Angina
01/2014 - 05/2002
2Acute Coronary Syndrome
11/2013 - 07/2013
2Necrosis
09/2013 - 11/2011
2Vascular Diseases (Vascular Disease)
08/2012 - 08/2003
2Peripheral Arterial Disease
08/2012 - 01/2005
2Abdominal Obesity
06/2012 - 08/2007
2Heart Diseases (Heart Disease)
12/2010 - 01/2007
2Isolated Systolic Hypertension
03/2005 - 09/2002
2Albuminuria
02/2005 - 09/2004
2Left Ventricular Dysfunction
01/2005 - 05/2002

Drug/Important Bio-Agent (IBA)

19Losartan (Cozaar)FDA LinkGeneric
02/2010 - 03/2002
18AntibodiesIBA
01/2022 - 01/2001
18Atenolol (Tenormin)FDA LinkGeneric
02/2010 - 03/2002
17Immunoglobulin M (IgM)IBA
01/2018 - 09/2006
16Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2009
15LipidsIBA
01/2022 - 08/2002
15Triglycerides (Triacylglycerol)IBA
03/2016 - 09/2002
14Phosphorylcholine (Phosphocholine)IBA
01/2022 - 09/2006
12CholesterolIBA
01/2022 - 04/2005
12HDL CholesterolIBA
03/2016 - 08/2002
11Interleukin-6 (Interleukin 6)IBA
08/2021 - 12/2005
11oxidized low density lipoproteinIBA
06/2012 - 01/2001
9Antihypertensive Agents (Antihypertensives)IBA
09/2009 - 03/2002
8ApolipoproteinsIBA
12/2021 - 09/2002
8Glucose (Dextrose)FDA LinkGeneric
10/2016 - 11/2004
7LDL CholesterolIBA
01/2020 - 08/2010
7LDL Lipoproteins (beta Lipoproteins)IBA
11/2013 - 03/2008
6Proteins (Proteins, Gene)FDA Link
04/2017 - 08/2010
6Lipoproteins (Lipoprotein)IBA
11/2013 - 09/2002
6C-Reactive ProteinIBA
12/2010 - 06/2003
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 02/2013
5Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2019 - 03/2012
5Insulin (Novolin)FDA Link
11/2017 - 11/2004
5lacidipineIBA
01/2014 - 09/2003
5AutoantibodiesIBA
01/2014 - 11/2003
5HDL LipoproteinsIBA
11/2013 - 06/2009
4Apolipoprotein A-I (Apolipoprotein A1)IBA
12/2021 - 08/2007
4Cytokine Receptor gp130IBA
08/2021 - 06/2015
4InterleukinsIBA
08/2021 - 05/2009
4Apolipoproteins E (ApoE)IBA
05/2013 - 04/2003
4Indicators and Reagents (Reagents)IBA
01/2013 - 03/2002
3Environmental Pollutants (Pollutants, Environmental)IBA
01/2022 - 01/2014
3Apolipoproteins B (ApoB)IBA
12/2021 - 08/2012
3Fibrinogen (Factor I)FDA Link
10/2021 - 08/2002
3Particulate MatterIBA
01/2021 - 03/2011
3Apolipoprotein B-100 (Apo B 100)IBA
09/2014 - 03/2008
3Plasminogen Activator Inhibitor 1IBA
09/2013 - 06/2003
3Angiotensin Receptor AntagonistsIBA
02/2010 - 09/2005
2Immunoglobulin G (IgG)IBA
01/2022 - 03/2008
2Interleukin-8 (Interleukin 8)IBA
01/2019 - 03/2014
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 09/2005
2Biological ProductsIBA
01/2018 - 09/2015
2PhosphatidylserinesIBA
01/2017 - 01/2014
2AlbuminsIBA
12/2016 - 09/2004
2Malondialdehyde (Propanedial)IBA
12/2016 - 01/2014
2Interleukin-5 (Interleukin 5)IBA
05/2016 - 03/2015
2Proprotein Convertase 9IBA
03/2016 - 06/2012
2Lipoprotein(a)IBA
03/2016 - 08/2012
2AdiponectinIBA
08/2015 - 01/2012
2Hormones (Hormone)IBA
06/2015 - 01/2012
2CreatinineIBA
01/2015 - 09/2004
2Messenger RNA (mRNA)IBA
09/2014 - 06/2012
225-hydroxyvitamin DIBA
06/2014 - 11/2013
2hydroxide ionIBA
06/2014 - 11/2013
2Cardiolipins (Cardiolipin)IBA
01/2014 - 01/2013
2EpitopesIBA
01/2014 - 06/2004
2Apolipoprotein C-I (Apolipoprotein C1)IBA
12/2010 - 09/2002
2Blood Coagulation Factors (Coagulation Factor)IBA
06/2010 - 05/2009
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2010 - 01/2005
2CytokinesIBA
09/2009 - 01/2001
2Hemoglobins (Hemoglobin)IBA
06/2009 - 01/2009
2EnzymesIBA
12/2008 - 08/2007
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2005 - 01/2005
2DiureticsIBA
01/2005 - 03/2002

Therapy/Procedure

8Therapeutics
06/2015 - 12/2003